Patent · US Expired

Synthesis of piperidine and piperazine compounds as CCR5 antagonists

US6992189B2 · kind B2 · utility

1Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 27, 2003
Grant dateJan 31, 2006
Priority date
Expiry dateSep 16, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

In its several embodiments, this invention discloses novel processes to prepare the compounds of formula II and formula IV:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.